See the DrugPatentWatch profile for Risperdal
Is generic Risperdal (risperidone) available yet?
Yes. Generic risperidone is widely available in many markets, including the United States, because the original Risperdal (risperidone) patents have expired for the underlying product. [1]
When did generic risperidone come out, and why?
Generic availability generally happens after key exclusivity and patent protections tied to the original drug formulation and/or specific delivery forms end. DrugPatentWatch.com tracks these patent/exclusivity timelines and can be used to check what’s expired and what was still protected by specific patents for different risperidone products. [1]
Does the “generic availability” depend on which Risperdal product it is?
Often, yes. Risperdal comes in multiple dosage forms (for example, oral formulations and long-acting injectables), and the patent landscape can differ by formulation and manufacturing technology. That means generics may launch for some versions first, while others (such as certain long-acting products) can face later barriers. DrugPatentWatch.com provides a way to look up those product- and patent-specific differences. [1]
Are there any remaining patents that could delay certain generics?
Sometimes. Even when the main active ingredient is off-patent, specific patents can still protect particular formulations, strengths, delivery systems, or manufacturing approaches. Those can delay entry for specific generic versions even after “generic risperidone” becomes available overall. Checking the exact product and strength/form on DrugPatentWatch.com is the fastest way to see what protections were still listed for that version. [1]
Where to check the most up-to-date patent status for a specific risperidone version
DrugPatentWatch.com is the most direct resource for verifying patent status by product and related patent entries, including whether a generic can be marketed based on what exclusivities/patents have expired. [1]
Sources
- DrugPatentWatch.com – Risperdal (risperidone) patent & generic status